Literature DB >> 26379931

In-hospital clinical outcomes of elderly patients (≥60 years) undergoing primary percutaneous coronary intervention.

Ya-Min Su1, Xing-Xing Cai1, Hai-Hua Geng1, Hong-Zhuan Sheng1, Meng-Kan Fan1, Min Pan1.   

Abstract

Elderly patients are at high risk of mortality when they present with ST-elevation myocardial infarction (STEMI). However, the clinical outcomes of this sub-group undergoing primary percutaneous coronary intervention (PPCI) have not been well established, despite recent advances in both devices and techniques. In the present retrospective cohort study from a Chinese single center, we assessed the clinical outcomes and predictors of mortality in elderly patients (≥60 years) underwent with PPCI. The primary endpoints were immediate angiographic success and in-hospital procedural success. The secondary endpoints were all-cause death in hospital. Between January 2011 and December 2013, a total of 184 consecutive patients with acute STEMI underwent PPCI were enrolled. 116 (63.04%) patients were in the elderly group. Despite the difference in lesion complexity between groups, the immediate angiographic success rate was similar (93.97% in the elderly group, and 94.12% in the non-elderly group, P=0.966). The procedural success rate were not significantly different between the two groups (90.52% in the elderly group, and 94.12% in the non-elderly group, P=0.389). However, in-hospital mortality was statistically higher in elderly group than in the non-elderly group (8.62% Vs 1.47%, P=0.048). The major causes of death were cardiac shock and malignant arrhythmias (ventricular tachycardia and fibrillation). Our results indicate that PPCI in the elderly is feasible and has a high likelihood of immediate angiographic and procedural success.

Entities:  

Keywords:  Coronary artery disease; ST-elevation myocardial infarction; elderly; primary percutaneous coronary intervention

Year:  2015        PMID: 26379931      PMCID: PMC4565314     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  33 in total

1.  Evaluation of heart function with impedance cardiography in acute myocardial infarction patients.

Authors:  Shun-Juan Chen; Zhu Gong; Qiang-Lin Duan
Journal:  Int J Clin Exp Med       Date:  2014-03-15

2.  Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology.

Authors:  Martial Hamon; Christian Pristipino; Carlo Di Mario; James Nolan; Josef Ludwig; Marco Tubaro; Manel Sabate; Josepa Mauri-Ferré; Kurt Huber; Kari Niemelä; Michael Haude; William Wijns; Dariusz Dudek; Jean Fajadet; Ferdinand Kiemeneij
Journal:  EuroIntervention       Date:  2013-03       Impact factor: 6.534

3.  Effect of platelet inhibition with cangrelor during PCI on ischemic events.

Authors:  Deepak L Bhatt; Gregg W Stone; Kenneth W Mahaffey; C Michael Gibson; P Gabriel Steg; Christian W Hamm; Matthew J Price; Sergio Leonardi; Dianne Gallup; Ezio Bramucci; Peter W Radke; Petr Widimský; Frantisek Tousek; Jeffrey Tauth; Douglas Spriggs; Brent T McLaurin; Dominick J Angiolillo; Philippe Généreux; Tiepu Liu; Jayne Prats; Meredith Todd; Simona Skerjanec; Harvey D White; Robert A Harrington
Journal:  N Engl J Med       Date:  2013-03-10       Impact factor: 91.245

4.  Serum levels of thrombotic markers in patients with acute myocardial infarction.

Authors:  Shafiqul Islam; Sobhy M Yakout; Nasser M Al Daghri; Abdullah S Alhomida; Haseeb A Khan
Journal:  Int J Clin Exp Med       Date:  2014-04-15

5.  Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction.

Authors:  Junjie Xiao; Bo Shen; Jin Li; Dongcao Lv; Yingying Zhao; Fei Wang; Jiahong Xu
Journal:  Int J Clin Exp Med       Date:  2014-01-15

6.  Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE]).

Authors:  Robert J Goldberg; Frederick A Spencer; Keith A A Fox; David Brieger; Ph Gabriel Steg; Enrique Gurfinkel; Rebecca Dedrick; Joel M Gore
Journal:  Am J Cardiol       Date:  2009-01-12       Impact factor: 2.778

7.  Association of angiotensin-converting enzyme gene 2350G>A polymorphism with myocardial infarction in a Chinese population.

Authors:  Min-Hui Jiang; Mei-Fang Wei; Zhi-Hua Liu; Wen-Ping Jiang; Hai-Hua Geng; Zhi-Chu Cui; Dong-Lei Zhang; Jian-Hua Zhu
Journal:  Clin Appl Thromb Hemost       Date:  2008-04-28       Impact factor: 2.389

8.  Angiotensin-converting enzyme gene 2350 G/A polymorphism is associated with left ventricular hypertrophy but not essential hypertension.

Authors:  Min Pan; Jian-Hua Zhu; Zhi-Hua Liu; Wen-Ping Jiang; Zhi-Chu Cui; Xiao-Hong Yu; Hong-Mei Li; Xiang-Jun Yang
Journal:  Hypertens Res       Date:  2007-01       Impact factor: 3.872

9.  Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries).

Authors:  Joo Myung Lee; Kyung Woo Park; Jung-Kyu Han; Han-Mo Yang; Hyun-Jae Kang; Bon-Kwon Koo; Jang-Whan Bae; Sung-Il Woo; Jin Sik Park; Dong-Kyu Jin; Dong Woon Jeon; Seok Kyu Oh; Jong-Seon Park; Doo-Il Kim; Min Su Hyon; Hui-Kyung Jeon; Do-Sun Lim; Myeong-Gon Kim; Seung-Woon Rha; Sung-Ho Her; Jin-Yong Hwang; Sanghyun Kim; Young Jin Choi; Jin Ho Kang; Keon-Woong Moon; Yangsoo Jang; Hyo-Soo Kim
Journal:  Am J Cardiol       Date:  2014-08-12       Impact factor: 2.778

10.  Randomized trial of preventive angioplasty in myocardial infarction.

Authors:  David S Wald; Joan K Morris; Nicholas J Wald; Alexander J Chase; Richard J Edwards; Liam O Hughes; Colin Berry; Keith G Oldroyd
Journal:  N Engl J Med       Date:  2013-09-01       Impact factor: 91.245

View more
  1 in total

1.  In-hospital major arrhythmias, arrhythmic death and resuscitation after successful primary percutaneous intervention for acute transmural infarction: a retrospective single-centre cohort study.

Authors:  Marco Albanese; Korhan Alpaslan; Taoufik Ouarrak; Peter Merguet; Steffen Schneider; Wolfgang Schöls
Journal:  BMC Cardiovasc Disord       Date:  2018-06-14       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.